GCT1015-05/ENGOT-cx8/GOG-3024
Trial Description:
A Phase 1b/2 open-Label Trial of Tisotumab Vedotin (Humax-TF-ADC) Monotherapy and in combination with other Agents in Subjects with recurrent or Stage IVB Cervical Cancer
Lead Cooperative Group:
Trial Number:
Disease Site:
Cervical
Trial Status:
Recruiting
Contact person:
ivergote